Skip to main content
Adding venetoclax improves ibrutinib outcomes in CLL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Adding venetoclax improves ibrutinib outcomes in CLL
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Remission
0
0.71
Skin Cancer
0
0.68
Bone Marrow
0
0.58
Toxicology
0
0.54
Neutropenia
0
0.5
Myelodysplastic Syndrome
0
0.43
Bone
0
0.41
Patient Safety
0
0.25
Nonmelanoma Skin Cancer
0
0.22
Cancer
0
0.2
Residual Disease
0
0.2
Chemotherapy
0
0.1
Leukemia
0
0.1
Peer Review
0
0.1
Texas
0
0.1
Tolerance
0
0.1
Tumor
0
0.1
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Edit Tags